4a/ $PVCT. Neuroendocrine tumors (NET) metastatic to the liver (mNET) refractory to somatostatin analogs and peptide receptor radionuclide therapy (NCT02693067) at the European Neuroendocrine Tumor Society annual conference. #ENETS22#ENETS2022. #rosebengal#rosebengalsodium.
5a/ $PVCT. High-risk and refractory adult solid tumor cancers (preclinical) at the annual meeting of the American Association for Cancer Research. #AACR22#AACR2022. #rosebengal#rosebengalsodium.
5b/ $PVCT. Identification and In Vivo Validation of Unique Anti-Oncogenic Properties and Mechanisms Involving Protein Kinase Signalling and Autophagy Mediated by the Investigational New Agent PV-10 (poster). provectusbio.com/media/docs/pub…. #rosebengal#rosebengalsodium.
6a/ $PVCT. Uveal melanoma (UM) metastatic to the liver (mUM) (NCT00986661) at the American Society of Clinical Oncology annual meeting. #ASCO22 # ASCO2022. #rosebengal#rosebengalsodium#PV-10.
29/ $PVCT entered into an option agreement with @univmiami for an exclusive worldwide license of #IP for the use of a photodynamic antimicrobial therapy medical device in combination with our pharmaceutical-grade #rosebengalsodium API for the treatment of eye infections.
30/ $PVCT received the nonproprietary name of #rosebengalsodium for our pharmaceutical-grade API from @WHO Expert Advisory Panel on the International Pharmacopoeia and Pharmaceutical Preparations, and reached the status of recommended International Nonproprietary Names.
31a/ $PVCT completed chemical analytical work to rigorously and methodically compare and contrast lots of commercial-grade rose bengal from different specialty chemical suppliers with our pharmaceutical-grade #rosebengalsodium API. #DrugManufacturing. #rosebengal.
31b/ $PVCT. Preliminary results indicated that all 3 commercial-grade rose bengal lots had drastically different rose bengal purity from that represented on their certificates of analysis. 1 lot also contained gross contaminants not represented on its certificate. THREAD END.
2/ Abstract Number: 606 - B0243. Echeverri Tribin F et al. Inhibition of Multidrug-Resistant Pseudomonas aeruginosa with Rose Bengal Photodynamic Antimicrobial Therapy: In vitro. Conclusions: MDR Pseudomonas aeruginosa can be inhibited by rose bengal eppro02.ativ.me/web/page.php?p…… twitter.com/i/web/status/1…
3/ Abstract Number: 609 - B0246. Krishna et al. In vitro Inhibition of Aspergillus and Fusarium Species with Erythrosin B, Eosin Y, and Rose Bengal Photodynamic Antimicrobial Therapy. Conclusions: EB, EY, and RB with light were effective against both F. eppro02.ativ.me/web/page.php?p…… twitter.com/i/web/status/1…
2/ “Everyone” seems to know or understand #RoseBengal, but do they (you) really?
3/ #RoseBengal is a small molecule (i.e., <1,000 Daltons*), but a “heavy” one at 973.67 Da or g/mol. It is heavy because of its four iodides, which comprise 52% of its molecular weight.
1/ “Hijacking antibody-induced CTLA-4 lysosomal degradation for safer and more effective cancer immunotherapy.” $PVCT thoughts: there’s no free lunch. A THREAD.
2/ 20Mar23: Endpoints: “BioNTech to pay $200M upfront in CTLA-4 antibody development, commercialization deal.” endpts.com/biontech-to-pa….
$PVCT-related medical journal article: DePalo DK, Zager JS. Advances in Intralesional Therapy for Locoregionally Advanced and Metastatic Melanoma: Five Years of Progress. Cancers. 2023; 15(5):1404. doi.org/10.3390/cancer…. @MoffittNews@USFHealthMed. Intralesional agent PV-10… twitter.com/i/web/status/1…
Other $PVCT work by Dr. Zager (and Moffitt Cancer Center) as a principal investigator for us: PV-10 (#RoseBengalSodium) + #Keytruda (#pembrolizumab) for immune checkpoint blockade-naïve Stage III cutaneous melanoma
Other $PVCT work by Dr. Zager (and Moffitt Cancer Center) as a principal investigator for us: PV-10 (#RoseBengalSodium) + #Keytruda (#pembrolizumab) for immune checkpoint blockade-refractory advanced melanoma
2/ Over the past decade-plus, cancer immunotherapy with antibodies targeting the PD-1 immune checkpoint pathway (i.e., PD-1 inhibitors #PD1) has yielded dramatic improvement in clinical outcome for many patients with #CutaneousMelanoma. #Keytruda#Opdivo#otherPD1s#PDL1s
3/ However, patients with Stage III disease and, in particular, those with in-transit disease (i.e., in-transit melanoma; ITM #IntransitMelanoma), have presented unique challenges with regard to response rate and durability of response.
2/ This $PVCT #thread will be an ongoing one for some time. Please check back to read it again (and again), and learn more about our medical scientific history and our lead molecule #RoseBengalSodium’s journey to becoming a multi-disease, broad-spectrum, therapeutic compound.
3/ #Covid has been a deeply painful experience, to say the least, for the U.S. and the world. It also marked a turning point in the advancement and expansion of our #HX medical science platform, as well as our lead molecule #RoseBengalSodium and the investigational drugs and drug… twitter.com/i/web/status/1…